Abstract
Background
Some laparoscopic gastrectomy (LG) patients are postoperatively diagnosed with locally advanced disease or lymph node metastasis. Few reports have reviewed the outcomes or validity of LG in such patients.
Methods
We retrospectively compared the outcomes of LG for gastric cancer patients postoperatively diagnosed with T3 (subserosal invasion) or higher or N1 (metastasis in 1–2 regional lymph nodes), or higher disease (n = 36), with open gastrectomy (OG) for c-stage I gastric cancer patients (n = 62).
Results
D1 plus lymph node dissection was performed in all patients in the LG group. Blood loss was significantly lower in the LG group than in the OG group (P < 0.0010). The mean postoperative hospital stay duration was significantly shorter in the LG group than in the OG group (P = 0.0016). In the LG group, lymph node metastasis occurred in 1 patient, peritoneal dissemination in 2 patients, and liver metastasis in 1 patient. The 5-year survival rate did not significantly differ between the LG and OG groups (90.00 vs. 94.52 %; P = 0.6517).
Conclusions
Given the similarity in long-term outcomes between the LG and OG groups, LG is an appropriate indication for gastric cancer patients postoperatively diagnosed with locally advanced disease or lymph node metastasis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kitano S, Iso Y, Moriyama M, Sugimachi K (1994) Laparoscopy-assisted Billroth I gastrectomy. Surg Laparosc Endosc 4:146–148
Huscher CG, Mingoli A, Sgarzini G, Sansonetti A, Di Paola M, Recher A, Ponzano C (2005) Laparoscopic versus open subtotal gastrectomy for distal gastric cancer: five-year results of a randomized prospective trial. Ann Surg 241:232–237
Kitano S, Shiraishi N, Fujii K, Yasuda K, Inomata M, Adachi Y (2002) A randomized controlled trial comparing open vs laparoscopy-assisted distal gastrectomy for the treatment of early gastric cancer: an interim report. Surgery 131:S306–S311
Association JGC (2011) Japanese classification of gastric carcinoma: 3rd English edition. Gastric Cancer 14:101–112
Association JGC (2011) Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 14:113–123
Fang C, Hua J, Li J, Zhen J, Wang F, Zhao Q, Shuang J, Du J (2014) Comparison of long-term results between laparoscopy-assisted gastrectomy and open gastrectomy with D2 lymphadenectomy for advanced gastric cancer. Am J Surg 208:391–396
Huang YL, Lin HG, Yang JW, Jiang FQ, Zhang T, Yang HM, Li CL, Cui Y (2014) Laparoscopy-assisted versus open gastrectomy with D2 lymph node dissection for advanced gastric cancer: a meta-analysis. Int J Clin Exp Med 7:1490–1499
Asao T, Yanagita Y, Nakamura J, Hosouchi Y, Takenoshita S, Nagamachi Y (1999) Usefulness of a visceral mini-retractor accessible without trocar port during laparoscopic surgery. Surg Endosc 13:91
Lee SR, Kim HO, Son BH, Shin JH, Yoo CH (2014) Laparoscopic-assisted total gastrectomy versus open total gastrectomy for upper and middle gastric cancer in short-term and long-term outcomes. Surg Laparosc Endosc Percutan Tech 24:277–282
Lu C, Zhou S, Peng Z, Chen L (2015) Quality of D2 lymphadenectomy for advanced gastric cancer: is laparoscopic-assisted distal gastrectomy as effective as open distal gastrectomy? Surg Endosc 29:1537–1544
Lin J, Huang C, Zheng C, Li P, Xie J, Wang J, Lu J (2014) A matched cohort study of laparoscopy-assisted and open total gastrectomy for advanced proximal gastric cancer without serosa invasion. Chin Med J (Engl) 127:403–407
Hosono S, Arimoto Y, Ohtani H, Kanamiya Y (2006) Meta-analysis of short-term outcomes after laparoscopy-assisted distal gastrectomy. World J Gastroenterol 12:7676–7683
Kawamura H, Yokota R, Homma S, Kondo Y (2009) Comparison of invasiveness between laparoscopy-assisted total gastrectomy and open total gastrectomy. World J Surg 33:2389–2395
Matsuhashi N, Osada S, Yamaguchi K, Saito S, Okumura N, Tanaka Y, Nonaka K, Takahashi T, Yoshida K (2013) Oncologic outcomes of laparoscopic gastrectomy: a single-center safety and feasibility study. Surg Endosc 27:1973–1979
Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, Furukawa H, Nakajima T, Ohashi Y, Imamura H, Higashino M, Yamamura Y, Kurita A, Arai K (2007) Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med 357:1810–1820
Sasako M, Sakuramoto S, Katai H, Kinoshita T, Furukawa H, Yamaguchi T, Nashimoto A, Fujii M, Nakajima T, Ohashi Y (2011) Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer. J Clin Oncol 29:4387–4393
Acknowledgments
The authors thank Ms. Yukie Saito, Ms. Tomoko Yano, Ms. Tomoko Ubukata, Ms. Yuka Matsui, Ms. Ayaka Ishida, and Ayaka Ishikubo for their excellent assistance.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Akiharu Kimura, Kyoichi Ogata, Norimichi Kogure, Toru Yanoma, Masaki Suzuki, Yoshitaka Toyomasu, Tetsuro Ohno, Erito Mochiki, and Hiroyuki Kuwano have declared no conflicts of interest or financial ties to disclose.
Rights and permissions
About this article
Cite this article
Kimura, A., Ogata, K., Kogure, N. et al. Outcome of laparoscopic gastrectomy with D1 plus lymph node dissection in gastric cancer patients postoperatively diagnosed with locally advanced disease or lymph node metastasis. Surg Endosc 30, 2090–2096 (2016). https://doi.org/10.1007/s00464-015-4462-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00464-015-4462-9